EarCentric EasyCharge vs Resound Vivia 9 60S microRIE

The EarCentric EasyCharge is a budget-priced prescription behind-the-ear hearing aid released in 2023, earning a C grade with a SoundScore of 2.7/5 in our lab testing. At $229, it sits at the entry level of the prescription hearing aid market. In our standardized testing, this device showed a significant performance gap compared to the prescription hearing aid category. Speech clarity scores were notably low, measuring 2.32 points below the category average in quiet environments and 0.96 points below average in noisy settings. Music streaming performance was similarly limited at 0.0/5, falling 2.64 points below average. Own-voice comfort scored 1.9/5, which is 0.85 points below the category norm. The EasyCharge's standout feature is its excellent feedback handling, scoring a perfect 5.0/5—0.29 points above the category average of 4.71. This means users are unlikely to experience whistling or squealing during everyday use. The device also offers convenient rechargeable batteries. Within the same budget price range, the RxEars Rxi achieves significantly stronger overall performance with a 4.09/5 SoundScore. Consumers prioritizing sound quality on a tight budget may find better value elsewhere, though the EasyCharge's feedback stability and rechargeable design could appeal to users with modest amplification needs who value convenience over maximum speech clarity.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.